Pivotal Scientific Limited supported Atlas Antibodies in their decision making on … Read more
Pivotal Scientific advises Atlas Antibodies on its purchase of Evitria
Atlas Antibodies wanted to make sure they were making the right move prior to purchasing Evitria, so they needed to know as much as possible about them and their technology. On behalf of Atlas Antibodies, Pivotal Scientific Limited completed end-to-end ‘commercial due diligence’, allowing Atlas Antibodies to learn more about Evitria in order to make a decision on the purchase. PSL also acted as the expert in supporting the overall business process.
Pivotal Scientific completed a deep-dive and reviewed the following:
• Overall market opportunity
• IVD market opportunity
• Market growth by region
• Competitive landscape
• The IVD market players
• Review of what makes Evitria special in terms of scientific capabilities
• Synergies, both cost and revenue.
Why did Atlas Antibodies need this information? To put it simply, due diligence and expert advisory arms you with the information you need to ensure that you’re going into a major acquisition with your eyes wide open, rather than relying on trust and ‘good faith’. It allows you in advance to really think about how your potential acquisition will fit with your current entity to strengthen both companies. Done properly, it can save you from making bad decisions and help protect your long term viability.
If you would like to find out more, contact Pivotal Scientific Limited today.
Sign up to our newsletter for the latest Industry insights and new technologies
Pivotal Scientific Limited (PSL) is pleased to announce … Read more
Pivotal Scientific are delighted to have advised the … Read more
Release Date: July 31st, 2019 Seattle, Washington State, … Read more
A successful transaction benefitting both parties. Pivotal Scientific … Read more
CliniSciences adds to its portfolio of companies Pivotal … Read more